Department of Molecular Medicine, Legal Medicine, University of Padua, Padua, Via Falloppio 50, 35121 Padua, Italy; Medico legal college of the Italian Society of Hemapheresis and Cellular Manipulation SIDEM.
Legal Medicine, AULSS "Pedemontana", Bassano del Grappa, Italy.
Transfus Apher Sci. 2020 Oct;59(5):102823. doi: 10.1016/j.transci.2020.102823. Epub 2020 May 23.
In healthcare systems of developed countries, obtaining informed consent is a necessary and fundamental requirement for the administration of any medical treatment. In Italy, for the administration of the recipient's informed consent for a blood transfusion, a pre-printed form is used in line with the Decree of the Ministry of Health dated 2 November 2015. This paper aims to analyse this form in light of the European legal provisions and following the enactment of Italian Law No. 219 of 2017 on informed consent and advance treatment directives. Our review shows that the structure of the form can be improved in light of the new direction provided by Italian law, the scientific advancement on transfusion risks, and the potential to reduce the use of blood components. Revising this form could be the opportune time to include written information on Patient Blood Management strategies. Though not exhaustive, this proposal may stimulate debate on the point and produce further contributions.
在发达国家的医疗体系中,获得知情同意是实施任何医疗的必要和基本要求。在意大利,为了获得受血者的输血知情同意书,根据 2015 年 11 月 2 日卫生部的法令,使用了预先印制的表格。本文旨在根据欧洲法律规定并遵循 2017 年意大利关于知情同意和预先治疗指示的第 219 号法律,对该表格进行分析。我们的审查表明,根据意大利法律提供的新方向、输血风险的科学进展以及减少血液成分使用的可能性,可以改进表格的结构。修订此表格可能是一个合适的时机,可以将有关患者血液管理策略的书面信息纳入其中。尽管不全面,但该提案可能会激发对此问题的讨论并产生更多的贡献。